EP2542276A1 - Système et méthode d'administration de médicaments à un patient - Google Patents

Système et méthode d'administration de médicaments à un patient

Info

Publication number
EP2542276A1
EP2542276A1 EP11706274A EP11706274A EP2542276A1 EP 2542276 A1 EP2542276 A1 EP 2542276A1 EP 11706274 A EP11706274 A EP 11706274A EP 11706274 A EP11706274 A EP 11706274A EP 2542276 A1 EP2542276 A1 EP 2542276A1
Authority
EP
European Patent Office
Prior art keywords
data
drug
patient
identification element
reading
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP11706274A
Other languages
German (de)
English (en)
Inventor
Hans-Otto Maier
Torsten DÖNHOFF
Horst Schmoll
Matthias Paetzold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Publication of EP2542276A1 publication Critical patent/EP2542276A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08—Sensors provided with means for identification, e.g. barcodes or memory chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150229—Pumps for assisting the blood sampling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150236—Pistons, i.e. cylindrical bodies that sit inside the syringe barrel, typically with an air tight seal, and slide in the barrel to create a vacuum or to expel blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150244—Rods for actuating or driving the piston, i.e. the cylindrical body that sits inside the syringe barrel, typically with an air tight seal, and slides in the barrel to create a vacuum or to expel blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150389—Hollow piercing elements, e.g. canulas, needles, for piercing the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381—Design of piercing elements
    • A61B5/150503—Single-ended needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150763—Details with identification means
    • A61B5/150786—Optical identification systems, e.g. bar codes, colour codes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/00584—Control arrangements for automatic analysers
    • G01N35/00722—Communications; Identification
    • G01N35/00871—Communications between instruments or with remote terminals
    • G01N2035/00881—Communications between instruments or with remote terminals network configurations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Definitions

  • the invention relates to a system and method for administering medicaments to a patient.
  • patients in particular intensive care units, are supplied with medicaments and optionally artificial food by means of one or more delivery devices, for example intravenously or by means of a stomach tube.
  • the delivery device may be an insulin delivery device that maintains the insulin value present within the patient's bloodstream at a predeterminable level in response to a previously measured blood glucose level in the patient's bloodstream.
  • feeding devices for at least one nutritional value of a food directly or indirectly supplied to the blood circulation with at least one food supply device can be administered to the patient.
  • such delivery devices even when incorporated into a drug and / or nutritional delivery system, require that the physician or other clinical personnel enter values underlying delivery by the delivery device. For example, quantity values, time intervals in which the supply should take place, interval-like feeds, etc., can be entered as the basis for the subsequent delivery of, for example, insulin.
  • This delivery is preceded by a mostly hand-drawn blood sample in the patient, which requires the interposition of clinical personnel.
  • additional clinical personnel are required who have the necessary expertise in the input functions of the delivery device, such as the infusion pump, to subsequently perform this delivery.
  • such delivery devices such as infusion pumps
  • a delivery rate represented as volume per unit time (ml / hr).
  • the dosage unit is used for an added drug solution. Accordingly, it is necessary that the dosage unit be converted into a delivery rate of the pump, which is the task of the doctor to be treated.
  • a disadvantage of such a conversion can often be computational errors, which leads to incorrect entries of the delivery rate and thus to an incorrect administration of insulin for the patient.
  • the input of the dosage unit is made possible with an infusion pump.
  • this requires the consideration of information on the concentration of the drug of the drug to be administered and on the nature of the drug. Both when specifying the concentration of the active ingredient and when entering the dose unit and the conversion of those in the delivery rate so far only the main active ingredients of the drug are taken into account. This is often sufficient if only or primarily a specific drug is to be administered.
  • Feeding or conveying devices for the supply of a drug solution mixture in a body are known several times.
  • devices / systems having a plurality of infusion and / or syringe pumps, each of which delivers a solution having at least one specific drug active to a body and thereby creating a drug-solution mixture are known.
  • the infusion pumps have the characteristics of continuous, accurate dosing of the medication in its delivery.
  • the pumps are integrated in a common order system, which usually has a central control unit, an operating unit and an alarm unit.
  • a common order system usually has a central control unit, an operating unit and an alarm unit.
  • the transfer of previously prepared medicaments, such as may be present within, for example, a syringe, to the actual infusion pump carries the risk of confusion with regard to the medication and the patient.
  • syringes with drugs contained therein of a predetermined dose assigned by the clinical staff of the wrong infusion pump and thus administered to the wrong patient are examples of a predetermined dose assigned by the clinical staff of the wrong infusion pump and thus administered to the wrong patient.
  • the central idea of the invention is that in a system for administering medicaments to a large number of patients, in particular a selected patient, the following features are present:
  • An identification element generating means for generating at least a first identification element with personal, drug and / or treatment-related first data to attach them to the medicament container; at least one reading device for reading the first data from / from the first identification element;
  • a feeding device for supplying the drug from the drug container inserted into the feeder in the patient;
  • the reading means is also adapted for reading second data mounted on / in a second identification element associated with the patient, and connected to the feeding means;
  • a control unit within the feeder sends a first control signal for activating the feed operation to one of a plurality of feed units of the feeder, provided that the first and second data are at least partially coincident.
  • Such a system is advantageously characterized by the fact that it provides a high level of security in the transfer of a prepared medicament in a dedicated medicine container to a respective delivery device of a patient for the correct assignment, because of the use of identification elements with or on it attached data is no longer possible confusion of such drug containers with the drugs contained therein. Rather, confusion of drugs is ruled out due to reading and comparing different data.
  • the feeder for comparing the first and second data with respect to the personal data match.
  • the person / patient can be compared with the personal data of the second data, which is a wristband or the like associated with the patient, according to the first data already used in drug preparation as an associate for the manufactured drug , can be taken.
  • the control unit would not give a release signal for activating the delivery process.
  • the supply device which may be an insulin pump, can not be activated. Rather, for example, the insulin pump can only be activated if it gets the right drug with the associated drug container, such as a syringe, used and a Identification of personal data on the syringe and on the patient.
  • a second comparison unit within the delivery device is provided for comparing the first medication-related data of the first data with the second medication-related data contained in a storage unit of the delivery device.
  • This allows pre-stored drug compositions within the storage unit of the delivery device to be compared to those drug compositions of the syringe used, thus precluding mis-prepared drugs having unrealistic drug compositions from being administered to the patient.
  • the second comparison unit of the feeder allows the second comparison unit of the feeder to a feeding process only if the first drug-related data of the first data, which are mounted on the identification element of the drug container, within a parameter or data range, which is permissible and suitable for the second drug-related Data is stored within the memory unit.
  • each composition of the previously prepared medicament can be automatically transferred to the identification element by the identification element generating device, so that it is ensured that no components or components are forgotten by the treating person.
  • a selection unit of the delivery device is arranged for at least partially selecting the first and / or second medication-related data.
  • This selector should be used to select the correct drug-related data.
  • parameters of the selected second drug-related data or selected first drug-related data may be altered to be able to administer a modified drug composition at other dosages based on recent events.
  • a disable unit for inhibiting the start of a feed operation is arranged on receipt of a second control signal of the control unit, wherein the control unit transmits this second control signal when the first and second data are not at least partially coincident.
  • Such a blocking unit has the task that the follow-up of the process, which should start a delivery process of a drug to the patient, from the side of the feeder is not possible if non-matching data are detected. This means that the process is automatically aborted by the device unless matching data is detected. This is intended to provide a high degree of security for a correct allocation of the medicament to the respective patient.
  • the identification element is advantageously a barcode label, a data matrix code label and / or a transponder.
  • Data matrix code label is printed from the identification element generating device and in the presence of a transponder, the data is stored by means of a writer on the transponder. This transponder can then be read at the feeder by means of a reader, whereas the barcode label and
  • Datamatrix code label can be read by means of a barcode scanner or data matrix code scanner.
  • the delivery device is an insulin pump
  • the delivery unit is one of a plurality of insulin pump units
  • the medicament container is a syringe.
  • Activating a delivery process for delivering the medicament to the patient with a delivery device by means of a first control signal of a control unit of the delivery device.
  • Such a method allows the automatic or automatic comparison of read data to ensure that only in the presence of a match of the read data, the process continues to be driven and thus a delivery process of the drug to the patient is possible. This results in a high degree of a secure allocation of the right drug to the right patient in order to avoid the administration of wrong medication and thus further unwanted symptoms of the patient.
  • a preferred embodiment of the inventive method is in a step of reading third data, which are attached to / in a third identification element, which is associated with a patient-handling, ensures that only the authorized person to be treated, ie a person from the clinical Personnel performing administration of the drug with proper assignment to the patient. Other persons thus have no access to the administering device, which represents the feeder. As a result, protection against unauthorized operation of the feeder and the delivery of drugs can be achieved.
  • a step of comparing first drug-related data of the first data with second drug-related data stored in a storage unit of the delivery device is provided.
  • the first medication-related data stored on the identification element can be compared with the second medication-related data stored in the storage unit and thus it can be determined whether the drug composition within the medication container corresponds to an approved medication composition range within which the drugs to be administered have to lie.
  • FIGS. 2a and 2b show the method according to the invention according to an embodiment of the invention.
  • Fig. 1 the system according to the invention an Ausstoryunsform of the invention is shown in a schematic representation.
  • a computer device 1 the medicament composition with the associated data relating to the person and the type of treatment is entered by the medical staff by means of a keyboard 2.
  • a barcode 5a is printed, which contains at least parts of the personal, drug and / or treatment-related first data.
  • This barcode is printed as a label and includes, for example as personal data, a patient identification number, as drug-related data, the name of the drug and its concentration, and as treatment-related data, various dosage parameters, such as the duration of the dosage.
  • the barcode label may have the words “Hans Müller”, “adrenaline”, “2mg / 50” in addition to the barcode or the Datamatrix code, meaning that a dosage of 2 mg / 50 for the drug adrenaline, which is within
  • the medicament is prepared in a composition in a medicament preparation station 4 and added to the syringe 5.
  • the barcode 5a is adhesively bonded to the syringe 5 by means of an adhesive surface.
  • the barcode label 5a is read in a reading device 6 by means of a barcode scanner 7, whereby the personal, drug-related and treatment-related data are read in within a feeder 11.
  • the reported data are then forwarded to a first comparison unit 15, which is preferably arranged within the feeder 11.
  • the comparison unit 15 compares the personal data, such as those arranged on the bracelet 10, for example by means of a bar code, with the personal data of the bar code label 5a, as originally produced by the computing unit 1 with reference to the drug produced by the drug preparation station 4 are. If, within the first comparison unit 15, a correspondence of the personal data but also, if necessary, of the drug-related data is determined, a corresponding signal is forwarded by the first comparison unit 15 to a control unit 16, which causes a first control signal 13 to be applied to the inserted infusion syringe by means of a control line 14 for actuating the feeding unit 12b for compressing the syringe 14 is sent.
  • syringes can be arranged in different delivery units 12a, 12b, 12c, 12d and 12e, which can be administered different medicaments for administration. to the patient.
  • the syringe 14 is the syringe 5 containing the drug as previously prepared.
  • the control unit 16 will send a corresponding signal to a blocking unit 20 in order to use this blocking unit to terminate the procedure and block the entire delivery device 11 to obtain.
  • a blocking unit 20 in order to use this blocking unit to terminate the procedure and block the entire delivery device 11 to obtain.
  • third data are read in by a nurse's bracelet containing the personal data of the nurse. These third data serve to compare them with permanently stored data, which may for example be contained in a memory unit 19, in order to establish that the nurse is authorized to operate this device or this supply device 11. If it is determined that this is other personal data, for example, because this nurse is not authorized to administer insulin, the ⁇ inhibit 20> is activated again in accordance with the signals of a control unit, which terminates the feeder operation 1 1 causes.
  • Medication-related data of the first data are compared with drug-related second data contained in the storage unit 19. This comparison takes place within a second comparison unit 18. If it is determined in such a comparison that deviations exist between the medicament-related first data read in by means of the barcode scanner 7 and the medicament-related second data from the storage unit 19, or if the first data lies outside a prescribed range for the second data by means of a display unit and input unit 17, the user or the nurse questions whether they still want to continue the treatment and what data they want to perform. As a result, the nurse may select the first medication-related data or the second medication-related data to continue the treatment.
  • the nurse can perform a change of the parameters on the delivery device 11 by means of the display and input unit 17 in order to change the dosage of the medication to be administered, for example. This is done in continuous data exchange with the control unit 16, which then in turn accordingly controls the feed unit 12b.
  • a corresponding failure signal is sent to the control unit 16 by means of a selection unit 21, which in turn controls the delivery unit 12b with the syringe 14 inserted therein in accordance with the selected data to start or optionally continue the feeding process.
  • a selection unit 21 controls the delivery unit 12b with the syringe 14 inserted therein in accordance with the selected data to start or optionally continue the feeding process.
  • an automated documentation of the administration parameters and of the entire delivery process as well as of the entire procedure is again automatically generated, this preferably taking place in the computer device 1. This can be done according to the arrow 22, for example by means of wireless LAN.
  • FIG. 2a and 2b the inventive method according to an embodiment of the invention is shown.
  • a step 25 the preparation of a drug is carried out according to parameters and data entered.
  • a step 26 an automated generation of a barcode label for application to a medicament container then takes place.
  • step 27 the application of the barcode label as an ID element is subsequently carried out by means of, for example, an adhesive surface.
  • reading 28 of the first data contained on the barcode label, preferably encrypted takes place.
  • a reading of second data 29, which are mounted on a bracelet in the form of a bar code label, preferably encrypted takes place.
  • a comparison between the first and second data is made for their match according to step 30, so as to bring about a termination of the entire process according to step 31 in the event of a mismatch.
  • reading 32 of third data takes place, which in turn is compared in a step 33 with data already stored in the insulin pump. This is data about the attending person to determine if this person is eligible. If this is denied, in a step 34 no admission to the treatment is allowed and a termination takes place.
  • first drug related data is compared to second drug related data for compliance. This is to ensure that not the drug-related data of the barcode, as it is attached to the syringe, unintentionally deviate from intended drug-related data areas that are already stored within the insulin pump. If such a comparison leads to a denial regarding the match, a termination of the process is carried out in a step 36.
  • step 35 If an affirmation of this comparison is determined according to step 35, a release signal is sent to one of the feed units and an activation of the feed operation in a step 37. Subsequently, in a step 38, display of feed parameters takes place.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

L'invention concerne un système et une méthode d'administration de médicaments à un patient. Le système comprend : au moins un récipient mobile pour médicaments (5), contenant au moins un médicament liquide; un dispositif de production (3) d'éléments d'identification pour générer au moins un premier élément d'identification (5a) comportant de premières données concernant la personne, les médicaments et/ou le traitement, pour apposer celui-ci sur le récipient pour médicaments (5); au moins un dispositif de lecture (6) pour la lecture des premières données présentes sur le premier élément d'identification (5a) ou dans celui-ci; au moins un dispositif d'alimentation pour acheminer le médicament hors du récipient pour médicaments (5, 14) placé dans le dispositif d'alimentation (11) au patient, le dispositif de lecture (6) étant également approprié pour la lecture de secondes données qui sont apposées sur un second élément d'identification (10) affecté au patient (9) ou introduites dedans, et étant relié au dispositif d'alimentation (11). Le système comprend également un dispositif de commande (16) à l'intérieur du dispositif d'alimentation (11) qui envoie un premier signal de commande (13) pour l'activation du processus d'alimentation à au moins une unité parmi une pluralité d'unités d'alimentation (12a à e) du dispositif d'alimentation (11), à condition que les premières et secondes données coïncident au moins en partie.
EP11706274A 2010-03-05 2011-03-03 Système et méthode d'administration de médicaments à un patient Ceased EP2542276A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102010010567 2010-03-05
DE102010012733 2010-03-24
PCT/EP2011/053246 WO2011107569A1 (fr) 2010-03-05 2011-03-03 Système et méthode d'administration de médicaments à un patient

Publications (1)

Publication Number Publication Date
EP2542276A1 true EP2542276A1 (fr) 2013-01-09

Family

ID=43920342

Family Applications (6)

Application Number Title Priority Date Filing Date
EP11707651.3A Not-in-force EP2542151B1 (fr) 2010-03-05 2011-03-03 Système de détermination de données thérapeutiques pour l'administration de médicaments à des patients à traiter avec prise en compte de facteurs de coefficient individuels
EP11706274A Ceased EP2542276A1 (fr) 2010-03-05 2011-03-03 Système et méthode d'administration de médicaments à un patient
EP11707397.3A Active EP2542992B1 (fr) 2010-03-05 2011-03-03 Système de transmission de données dans la determination de parametres de médicaments
EP11706599.5A Active EP2542142B1 (fr) 2010-03-05 2011-03-03 Système d'administration de médicaments avec prise en compte de valeurs urinaires
EP11706276A Ceased EP2542886A1 (fr) 2010-03-05 2011-03-03 Système et procédé de surveillance d'au moins un paramètre sanguin
EP11706275A Ceased EP2542991A1 (fr) 2010-03-05 2011-03-03 Système et procédé permettant de surveiller l'intervalle de temps lors d'opérations de surveillance de paramètres sanguins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP11707651.3A Not-in-force EP2542151B1 (fr) 2010-03-05 2011-03-03 Système de détermination de données thérapeutiques pour l'administration de médicaments à des patients à traiter avec prise en compte de facteurs de coefficient individuels

Family Applications After (4)

Application Number Title Priority Date Filing Date
EP11707397.3A Active EP2542992B1 (fr) 2010-03-05 2011-03-03 Système de transmission de données dans la determination de parametres de médicaments
EP11706599.5A Active EP2542142B1 (fr) 2010-03-05 2011-03-03 Système d'administration de médicaments avec prise en compte de valeurs urinaires
EP11706276A Ceased EP2542886A1 (fr) 2010-03-05 2011-03-03 Système et procédé de surveillance d'au moins un paramètre sanguin
EP11706275A Ceased EP2542991A1 (fr) 2010-03-05 2011-03-03 Système et procédé permettant de surveiller l'intervalle de temps lors d'opérations de surveillance de paramètres sanguins

Country Status (14)

Country Link
US (6) US20130023819A1 (fr)
EP (6) EP2542151B1 (fr)
JP (6) JP2013517030A (fr)
CN (5) CN102762144B (fr)
AU (6) AU2011222946B2 (fr)
BR (6) BR112012019624A2 (fr)
CA (6) CA2788603C (fr)
ES (2) ES2904601T3 (fr)
IL (6) IL220765B (fr)
MX (6) MX2012009598A (fr)
PL (1) PL2542142T3 (fr)
RU (6) RU2530590C2 (fr)
SG (6) SG183354A1 (fr)
WO (6) WO2011107571A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2741629C2 (ru) * 2016-09-20 2021-01-28 Бракко Дайэгностикс Инк. Системы и способы производства, инфузионного ввода и контроля доставки радиоактивного изотопа
US11810685B2 (en) 2018-03-28 2023-11-07 Bracco Diagnostics Inc. Early detection of radioisotope generator end life

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US9514131B1 (en) * 2010-05-30 2016-12-06 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10492991B2 (en) 2010-05-30 2019-12-03 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10262112B2 (en) 2013-02-04 2019-04-16 Precera Bioscience, Inc. Prescription decision support system and method using comprehensive multiplex drug monitoring
DE102014105058A1 (de) * 2014-04-09 2015-10-15 Stephanie Ittstein Vorrichtung zu einer Herstellung und/oder zu einer Verabreichung
JP6391312B2 (ja) * 2014-06-13 2018-09-19 クラリオン株式会社 端末接続装置、処理情報実行システム、及び処理情報実行方法
WO2016057982A1 (fr) 2014-10-10 2016-04-14 Nxstage Medical, Inc. Dispositifs, procédés, et systèmes d'équilibrage de débits
US11714975B2 (en) 2014-10-28 2023-08-01 Avery Dennison Retail Information Services Llc High density read chambers for scanning and encoding RFID tagged items
US20160314185A1 (en) * 2015-04-27 2016-10-27 Microsoft Technology Licensing, Llc Identifying events from aggregated device sensed physical data
DE102016005131A1 (de) * 2016-04-27 2017-11-02 Justus-Liebig-Universität Giessen Vorrichtung und Verfahren zur Verhinderung von Fehlzuleitungen eines Arzneimittels
US10045725B2 (en) * 2016-05-13 2018-08-14 Hugh Califf Blood analysis method and apparatus
US10814922B2 (en) * 2016-05-20 2020-10-27 Magna Exteriors Inc. Active underbody panel systems
WO2018017623A1 (fr) 2016-07-18 2018-01-25 Nxstage Medical, Inc. Dispositifs, procédés, et systèmes d'équilibrage de débits
US11865243B2 (en) 2016-08-30 2024-01-09 Nxstage Medical, Inc. Parameter monitoring in medical treatment systems
EP3669912A1 (fr) * 2018-12-19 2020-06-24 Sanofi Dispositif pour l'administration de médicaments et système pour l'administration de médicaments
EP4115815A4 (fr) * 2020-03-27 2023-08-09 TERUMO Kabushiki Kaisha Dispositif d'estimation de fonction biologique, et procédé d'estimation de fonction biologique
TWI811641B (zh) * 2021-03-04 2023-08-11 宏碁股份有限公司 用藥風險評估方法與用藥風險評估裝置
WO2023101996A1 (fr) * 2021-11-30 2023-06-08 Tandem Diabetes Care, Inc. Schéma d'autorisations et d'attribution de priorité de bolus pour système de pompe à perfusion

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5713856A (en) * 1995-03-13 1998-02-03 Alaris Medical Systems, Inc. Modular patient care system

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151845A (en) * 1977-11-25 1979-05-01 Miles Laboratories, Inc. Blood glucose control apparatus
JPS5521905A (en) * 1978-08-02 1980-02-16 Nikkiso Co Ltd Improvement of artificial pancreas
US4449538A (en) * 1982-01-25 1984-05-22 John Corbitt Medical-electronic body fluid accounting system
SU1458824A1 (ru) * 1987-02-19 1989-02-15 Московский медицинский стоматологический институт им.Н.А.Семашко Способ определени нарушени активности фибриногена плазмы крови
SU1686361A1 (ru) * 1988-04-05 1991-10-23 Самарский медицинский институт им.Д.И.Ульянова Способ определени функциональной активности клеток крови доноров
US5956501A (en) * 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5590648A (en) * 1992-11-30 1997-01-07 Tremont Medical Personal health care system
WO1995012812A1 (fr) * 1993-11-02 1995-05-11 Private Clinic Laboratories, Inc. Methode de controle de l'observation par un patient des prescriptions medicales
JP3243103B2 (ja) * 1994-02-04 2002-01-07 吉彦 鈴木 血糖値の制御装置
US7384410B2 (en) * 1995-03-13 2008-06-10 Cardinal Health 303, Inc. System and method for managing patient care
JPH09329597A (ja) * 1996-06-11 1997-12-22 Hitachi Ltd 尿沈渣検査システム
JPH10274656A (ja) * 1997-03-28 1998-10-13 Kdk Corp グルコース濃度の測定方法
US6579690B1 (en) * 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US7760187B2 (en) * 2004-07-30 2010-07-20 Apple Inc. Visual expander
US8480580B2 (en) * 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6074345A (en) * 1998-10-27 2000-06-13 University Of Florida Patient data acquisition and control system
RU2148257C1 (ru) * 1999-06-01 2000-04-27 Тверская государственная медицинская академия Способ исследования крови
US6423035B1 (en) * 1999-06-18 2002-07-23 Animas Corporation Infusion pump with a sealed drive mechanism and improved method of occlusion detection
US6790198B1 (en) * 1999-12-01 2004-09-14 B-Braun Medical, Inc. Patient medication IV delivery pump with wireless communication to a hospital information management system
US6519569B1 (en) * 1999-12-01 2003-02-11 B. Braun Medical, Inc. Security infusion pump with bar code reader
US20030154108A1 (en) * 2000-03-01 2003-08-14 Gambro, Inc. Extracorporeal blood processing information management system
JP2001245874A (ja) * 2000-03-03 2001-09-11 Sefa Technology Kk 赤血球沈降速度測定用採血管、採血管ホルダ、採血管運搬用プロテクタ、赤血球沈降速度測定方法およびその測定装置
DE10011395A1 (de) * 2000-03-09 2001-09-20 Braun Melsungen Ag Fluid-Bilanzierungssystem
US7630908B1 (en) * 2000-05-01 2009-12-08 John Amrien Wireless electronic prescription scanning and management system
GB0030809D0 (en) * 2000-12-16 2001-01-31 Schmidt Paul Sample tracking systems
WO2002049503A2 (fr) * 2000-12-19 2002-06-27 University Of Rochester Methode et dispositif d'administration de medicament et/ou de placebo
EP1364666A1 (fr) * 2000-12-27 2003-11-26 Philips Japan, Ltd Systeme de controle de l'information d'un dispositif de traitement sanguin et de l'information biologique, dispositif de controle de l'information d'un dispositif de traitement sanguin et de l'information biologique, et procede de commande correspondant
US7473224B2 (en) * 2001-05-29 2009-01-06 Ethicon Endo-Surgery, Inc. Deployable ultrasound medical transducers
AU2002365821A1 (en) * 2001-11-30 2003-06-17 British Telecommunications Public Limited Company Data transmission
RU2226689C2 (ru) * 2001-12-27 2004-04-10 Медицинский радиологический научный центр РАМН Способ определения сопротивляемости организма
US20030141981A1 (en) * 2002-01-29 2003-07-31 Tuan Bui System and method for operating medical devices
US20030212379A1 (en) * 2002-02-26 2003-11-13 Bylund Adam David Systems and methods for remotely controlling medication infusion and analyte monitoring
DE10226212A1 (de) * 2002-06-13 2003-12-24 Philips Intellectual Property Eignungsprüfungssystem
DE20217847U1 (de) * 2002-11-19 2004-04-08 B. Braun Melsungen Ag Sekretsammelvorrichtung
US20040172284A1 (en) * 2003-02-13 2004-09-02 Roche Diagnostics Corporation Information management system
ZA200508816B (en) * 2003-04-23 2008-01-30 Vasogen Ireland Ltd Dispensing systems
JP2006524069A (ja) * 2003-04-23 2006-10-26 バソジェン アイルランド リミテッド 放出装置
US7258673B2 (en) * 2003-06-06 2007-08-21 Lifescan, Inc Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein
WO2004112603A1 (fr) * 2003-06-19 2004-12-29 Wayne State University Systeme d'identification de reponse d'un patient suite a une perfusion d'anesthesie
US20050019943A1 (en) 2003-07-09 2005-01-27 Chaoui Sam M. Automatic blood analysis and identification system
US20050021368A1 (en) * 2003-07-25 2005-01-27 Debra Burkeen Enhanced safety medication administration system
US20050021367A1 (en) * 2003-07-25 2005-01-27 Deborah Saeger Medication administration system
JP2005102960A (ja) * 2003-09-30 2005-04-21 Seiko Epson Corp 点滴支援システム、点滴支援装置および点滴装置、並びに点滴方法
TW200519382A (en) * 2003-11-21 2005-06-16 Vasogen Ireland Ltd Medical material handling systems
US20050154368A1 (en) * 2003-11-21 2005-07-14 Vasogen Ireland Limited Medical material handling systems
RU2006121976A (ru) * 2003-11-21 2007-12-27 Вэсоджен Айэлэнд Лимитед (Ie) Системы управления консервативным лечением
US7172115B2 (en) * 2004-04-02 2007-02-06 Riptide Systems, Inc. Biometric identification system
US8518021B2 (en) * 2004-05-27 2013-08-27 Baxter International Inc. Apparatus and method for therapeutic delivery of medication
US8359338B2 (en) * 2004-07-30 2013-01-22 Carefusion 303, Inc. System and method for managing medical databases for patient care devices
EP1784162A2 (fr) * 2004-08-23 2007-05-16 Remote Clinical Solutions, Inc. Systeme et procede permettant de modifier un fluide en vue d'une administration orale
US20060042631A1 (en) * 2004-08-31 2006-03-02 Martin James F Apparatus to deliver oxygen to a patient
US20080027409A1 (en) * 2004-09-09 2008-01-31 Rudko Robert I Patient hydration/fluid administration system and method
US7727222B2 (en) * 2004-09-09 2010-06-01 Plc Medical Systems, Inc. Patient hydration system with taper down feature
RU2275640C1 (ru) * 2004-09-20 2006-04-27 Илья Николаевич Медведев Способ выбора метода лечения тромбоцитопатии при метаболическом синдроме
NZ556345A (en) * 2005-02-11 2010-04-30 Carefusion 303 Inc Identification system for use with an infussion pump that checks drugs against a patients data before use
US7785258B2 (en) * 2005-10-06 2010-08-31 Optiscan Biomedical Corporation System and method for determining a treatment dose for a patient
US8956291B2 (en) * 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
US7509156B2 (en) 2005-05-18 2009-03-24 Clarian Health Partners, Inc. System for managing glucose levels in patients with diabetes or hyperglycemia
KR100716015B1 (ko) * 2005-06-08 2007-05-08 유재천 란셋 장치 및 이를 이용한 혈액의 채취 및 주입 방법
US20070088333A1 (en) * 2005-10-13 2007-04-19 G&L Consulting, Llc Method and system for infusing an osmotic solute into a patient and providing feedback control of the infusing rate
US20070100256A1 (en) * 2005-10-28 2007-05-03 Sansom Gordon G Analyte monitoring system with integrated lancing apparatus
US8543420B2 (en) * 2007-09-19 2013-09-24 Fresenius Medical Care Holdings, Inc. Patient-specific content delivery methods and systems
US8140353B2 (en) 2006-06-29 2012-03-20 The Invention Science Fund I, Llc Compliance data for health-related procedures
CA2657652C (fr) * 2006-07-13 2015-05-12 Jody Ann Tirinato Acquisition de donnees medicales et systeme et procede de prise en charge du patient
CN1987962A (zh) * 2006-09-27 2007-06-27 上海博维康讯信息科技发展有限公司 一种一次性病人腕带及病人身份识别系统
RU2316765C1 (ru) * 2006-09-28 2008-02-10 Илья Николаевич Медведев Способ раннего выявления ослабления антитромботической активности сосудов
RU2328000C1 (ru) * 2006-11-27 2008-06-27 Илья Николаевич Медведев Способ раннего выявления тромбопластинообразования
WO2008078713A1 (fr) * 2006-12-22 2008-07-03 Konami Digital Entertainment Co., Ltd. Arme-jouet de tir pour jeux à deux joueurs
US9326742B2 (en) 2007-01-01 2016-05-03 Bayer Healthcare Llc Systems for integrated radiopharmaceutical generation, preparation, transportation and administration
JP2008224385A (ja) 2007-03-12 2008-09-25 Olympus Corp 分析装置および分析方法
EP2131723B1 (fr) * 2007-03-19 2013-07-24 Insuline Medical Ltd. Dispositif pour mesure de substance
US8412293B2 (en) * 2007-07-16 2013-04-02 Optiscan Biomedical Corporation Systems and methods for determining physiological parameters using measured analyte values
US7972296B2 (en) 2007-10-10 2011-07-05 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8417311B2 (en) * 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US20080306434A1 (en) 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
US20090004317A1 (en) * 2007-06-30 2009-01-01 Xuejiao Hu High thermal conductivity molding compound for flip-chip packages
WO2009029899A1 (fr) 2007-09-01 2009-03-05 Sang Hoon Woo Contrôle de condition de liquides organiques à l'aide de diurétiques
US8326650B2 (en) * 2007-09-07 2012-12-04 Terumo Kabushiki Kaisha Blood sugar measuring device
DE102007047351A1 (de) * 2007-10-02 2009-04-09 B. Braun Melsungen Ag System und Verfahren zur Überwachung und Regelung von Blutglukosewerten
JP5188780B2 (ja) * 2007-11-08 2013-04-24 日機装株式会社 血液浄化装置及びそれによる治療終了の報知方法
RU2371723C1 (ru) * 2008-03-03 2009-10-27 Государственное учреждение Научный центр реконструктивной и восстановительной хирургии Восточно-Сибирского научного центра Сибирского отделения Российской Академии медицинских наук Способ оценки устойчивости эритроцитов к функциональной нагрузке
JP2009273502A (ja) * 2008-05-12 2009-11-26 Jms Co Ltd 投薬監視装置
US20090307008A1 (en) * 2008-06-04 2009-12-10 Cardinalhealth Blood infusion management system and method
US20100036310A1 (en) * 2008-08-05 2010-02-11 Hillman Robert S Integrated patient management and control system for medication delivery
US20100160854A1 (en) * 2008-12-22 2010-06-24 Gauthier Robert T Integrated patient management and control system for medication delivery

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5713856A (en) * 1995-03-13 1998-02-03 Alaris Medical Systems, Inc. Modular patient care system

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2741629C2 (ru) * 2016-09-20 2021-01-28 Бракко Дайэгностикс Инк. Системы и способы производства, инфузионного ввода и контроля доставки радиоактивного изотопа
RU2742349C2 (ru) * 2016-09-20 2021-02-05 Бракко Дайэгностикс Инк. Система доставки радиоактивных изотопов с некоторым количеством детекторов для регистрации гамма-излучения и бета-излучения
US11752254B2 (en) 2016-09-20 2023-09-12 Bracco Diagnostics Inc. Radioisotope delivery system with multiple detectors to detect gamma and beta emissions
US11865298B2 (en) 2016-09-20 2024-01-09 Bracco Diagnostics Inc. Systems and techniques for generating, infusing, and controlling radioisotope delivery
US11810685B2 (en) 2018-03-28 2023-11-07 Bracco Diagnostics Inc. Early detection of radioisotope generator end life

Also Published As

Publication number Publication date
AU2011222942B2 (en) 2014-05-08
AU2011222947A1 (en) 2012-07-26
AU2011222943B2 (en) 2014-08-28
US20130023851A1 (en) 2013-01-24
US20130023819A1 (en) 2013-01-24
WO2011107569A1 (fr) 2011-09-09
CA2789191A1 (fr) 2011-09-09
EP2542151B1 (fr) 2015-05-06
BR112012021524A2 (pt) 2016-07-05
EP2542991A1 (fr) 2013-01-09
CN102741850A (zh) 2012-10-17
US20120323215A1 (en) 2012-12-20
CN102804191A (zh) 2012-11-28
MX2012009058A (es) 2012-09-07
CA2789188C (fr) 2020-04-07
US20120323141A1 (en) 2012-12-20
JP2013521543A (ja) 2013-06-10
SG183254A1 (en) 2012-09-27
CN102762240A (zh) 2012-10-31
RU2012127707A (ru) 2014-01-20
IL220765B (en) 2018-04-30
MX2012008822A (es) 2012-09-07
BR112012020270A2 (pt) 2016-05-03
CA2786302C (fr) 2016-02-23
SG183352A1 (en) 2012-09-27
IL220765A0 (en) 2012-08-30
CA2788603A1 (fr) 2011-09-09
BR112012020270B1 (pt) 2022-02-15
JP5758409B2 (ja) 2015-08-05
JP5658767B2 (ja) 2015-01-28
AU2011222943A1 (en) 2012-08-30
MX2012009373A (es) 2012-09-12
CN102762240B (zh) 2017-03-08
WO2011107568A1 (fr) 2011-09-09
EP2542151A1 (fr) 2013-01-09
SG183353A1 (en) 2012-09-27
RU2012132703A (ru) 2014-02-10
EP2542142A1 (fr) 2013-01-09
CN102762144B (zh) 2015-07-08
RU2012130366A (ru) 2014-01-27
BR112012020923A2 (pt) 2020-01-14
IL221166B (en) 2018-06-28
ES2904601T3 (es) 2022-04-05
RU2522270C2 (ru) 2014-07-10
WO2011107571A1 (fr) 2011-09-09
IL221373A (en) 2015-06-30
EP2542886A1 (fr) 2013-01-09
WO2011107567A1 (fr) 2011-09-09
IL221413A0 (en) 2012-10-31
SG183118A1 (en) 2012-09-27
CA2787324A1 (fr) 2011-09-09
AU2011222946B2 (en) 2014-10-02
JP5485414B2 (ja) 2014-05-07
US9861745B2 (en) 2018-01-09
EP2542992B1 (fr) 2017-11-08
AU2011222944A1 (en) 2012-08-30
CA2786302A1 (fr) 2011-09-09
US20120316465A1 (en) 2012-12-13
CA2788057A1 (fr) 2011-09-09
SG183354A1 (en) 2012-09-27
PL2542142T3 (pl) 2022-03-21
JP2013520718A (ja) 2013-06-06
RU2012134289A (ru) 2014-02-27
RU2543941C2 (ru) 2015-03-10
JP2013520217A (ja) 2013-06-06
CA2788603C (fr) 2017-05-23
MX2012009596A (es) 2012-09-12
AU2011222942A1 (en) 2012-08-30
JP5592506B2 (ja) 2014-09-17
CA2789188A1 (fr) 2011-09-09
IL221373A0 (en) 2012-10-31
AU2011222945A1 (en) 2012-09-06
BR112012019624A2 (pt) 2016-05-03
CA2789191C (fr) 2017-10-31
JP2013517030A (ja) 2013-05-16
IL221166A0 (en) 2012-09-24
AU2011222946A1 (en) 2012-08-16
RU2517562C2 (ru) 2014-05-27
CN102834048A (zh) 2012-12-19
MX2012009598A (es) 2012-09-12
JP2013517871A (ja) 2013-05-20
CA2788057C (fr) 2014-12-02
CA2787324C (fr) 2018-04-17
IL221412A (en) 2016-07-31
CN102713615A (zh) 2012-10-03
MX2012008144A (es) 2012-08-03
AU2011222945B2 (en) 2014-02-06
CN102762144A (zh) 2012-10-31
SG182546A1 (en) 2012-08-30
RU2012133280A (ru) 2014-02-10
CN102834048B (zh) 2016-03-30
BR112012021524B1 (pt) 2021-10-13
BR112012019133A2 (pt) 2018-03-27
EP2542142B1 (fr) 2021-11-17
BR112012017543A2 (pt) 2016-06-28
IL221413B (en) 2020-07-30
RU2530590C2 (ru) 2014-10-10
RU2526141C2 (ru) 2014-08-20
RU2524121C2 (ru) 2014-07-27
IL221412A0 (en) 2012-10-31
WO2011107566A1 (fr) 2011-09-09
IL221009A (en) 2017-05-29
RU2012134290A (ru) 2014-02-20
WO2011107570A1 (fr) 2011-09-09
EP2542992A1 (fr) 2013-01-09
AU2011222944B2 (en) 2013-12-19
ES2655370T3 (es) 2018-02-19
JP2013519481A (ja) 2013-05-30
US20130085471A1 (en) 2013-04-04
AU2011222947B2 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
EP2542276A1 (fr) Système et méthode d'administration de médicaments à un patient
DE102008056013B4 (de) Patientenbehandlungsplanungssystem sowie computerimplementiertes Verfahren zum Erstellen eines Patientenbehandlungsplans
DE102005022428A1 (de) Verfahren und Vorrichtung zur Steuerung einer Mehrzahl von Infusionspumpen
DE60315443T2 (de) Patientenkontrollierte aktivierung von implantierbaren vorrichtungen zur verabreichung von arzneien
EP2207582B1 (fr) Systeme et procede pour controler et reguler des taux de glycemie
DE10352456A1 (de) Verfahren und Vorrichtung zur Verabreichung von flüssigen Medikamenten an einem Patienten
EP1936524B1 (fr) Dispositif de traitement de sang
EP0960627A2 (fr) Dispositif de contrÔle et/ou de surveillance pour pompes de perfusion
DE3390462T1 (de) Programmierbare Steuereinrichtung für die Durchführung von Infusionen für medizinische Zwecke
DE3812584A1 (de) Vorrichtung zur biofeedbackkontrolle von koerperfunktionen
DE102011089620B4 (de) Medizinische Injektionsvorrichtung und Verfahren zu deren Steuerung
DE60210302T2 (de) Verfahren zum sicheren übertragen von patientendaten auf einem/einen datenträger
EP2504784A2 (fr) Système d'injection
DE102018104720A1 (de) Injektor
EP2195758B1 (fr) Système de transport et procédé pour l'administration d'un mélange de solutions médicamenteuses
DE10148838A1 (de) Verfahren und Vorrichtung zum Fernüberwachen einer Wirkung eines Medikamentes
WO2005081164A2 (fr) Procede et systeme d'information pour realiser un examen clinique sur un patient
EP3107019A1 (fr) Procédé, produit-programme informatique et système d'échange de données médicales
DE102021127476A1 (de) System und Verfahren zur Bereitstellung einer Medikation an einem medizinischen Gerät
EP1235179B1 (fr) Système de collection et de stockage de données personnelles et élément de mémoire associé et méthode de sauvetage et de traitement médical d'un être vivant en urgence
DE10220031A1 (de) Infusions-Dosiersystem
EP3782096A1 (fr) Contrôle de prise réalisé indépendamment du lieu
DE202014010548U1 (de) Registrierungssystem zum Anlegen und/oder Führen einer persönlichen Medikationsakte mithilfe eines Rechnersystems
DE10162654A1 (de) Vorrichtung zur Verordnung, Überwachung und Speicherung von an Patienten verordneten, verabreichten bzw. zu verabreichenden Medikamenten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

APBK Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOSNREFNE

APBN Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2E

APBR Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3E

APAV Appeal reference deleted

Free format text: ORIGINAL CODE: EPIDOSDREFNE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

APBT Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9E

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20210615